U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962995) titled 'Multi-Cancer Detection Observational Cohort Study' on April 30.
Brief Summary: This study proposes a prospective observational registry study involving patients who have undergone clinical MCD testing at Mayo Clinic or referred to Mayo Clinic with Multi-Cancer Detection (MCD) test results for further evaluation and management.Novel, high-performance genomic technologies now allow detection of signals from cancers in the blood, giving rise to a new paradigm of MCD tests. Blood is inherently well suited for detection of cancer biomarkers as it contains circulating tumor cells and tumor cell-free DNA (cfDNA) that have been "shed" from an...